Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the single-cell omics market grown in recent years?

In recent times, the single-cell omics market has been expanding at a speedy pace. It is estimated to grow from $2.08 billion in 2024 to approximately $2.41 billion in 2025, with a compound annual growth rate (CAGR) of 15.9%. The historical growth of this market can be linked to the discovery of cellular heterogeneity, the development of single-cell analysis apparatus, advancements in biomedical research, characterization of the immune system, as well as the surge in precision medicine.

How is the single-cell omics market size expected to evolve during the forecast period?

Rapid expansion is anticipated in the single-cell omics market size over the next few years. It’s projected to rise to $4.52 billion by 2029, growing at a compound annual growth rate (CAGR) of 17.0%. The predicted increase during this period is due to factors such as its clinical adoption in diagnostics, combination with multi-omics strategies, and utilization in regenerative medicine, drug development and discovery, as well as cellular therapies and immunotherapies. The key trends in the forecast period are in vivo single-cell studies, applying single-cell omics in infectious disease investigation, techniques of microfluidics and single-cell sorting, integration of single-cell multi-omics, and spatial profiling of single cells.

Get your single-cell omics market report here!

https://www.thebusinessresearchcompany.com/report/single-cell-omics-global-market-report

Which key drivers are propelling the single-cell omics market’s growth?

The increasing occurrence of cancer is anticipated to drive the expansion of the single-cell omics market. Cancer, a group of diseases that may develop in almost any organ or tissue of the body when cells grow out of control, break their usual boundaries and either spread to other organs or invade neighboring parts of the body, is contributing to this growth. The use of single-cell omics data has been vital in identifying cancer biomarkers, predicting prognoses, and discovering new therapeutic targets in predetermined clinical groups. For example, the National Institutes of Health, a US government agency, reported in May 2024 that about 18.1 million individuals in the United States were living as cancer survivors as of January 2022. This figure is projected to increase to 22.5 million by 2032. Thus, the growing incidence of cancer is fuelling the single-cell omics market’s growth.

What are the market segments in the single-cell omics industry?

The single-cell omics market covered in this report is segmented –

1) By Product: Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics

2) By Technology: Cell Isolation Technologies, Sample Preparation Technologies, Analysis Of Next-Generation Sequencing

3) By Application: Oncology, Cell Biology, Neurology, Immunology

4) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Organizations, Hospital And Diagnostic Laboratories, Other End Users

Subsegments:

1) By Single-Cell Genomics: Whole Genome Sequencing (WGS), Targeted Sequencing, Single-Cell DNA Analysis Kits

2) By Single-Cell Transcriptomics: RNA Sequencing (RNA-seq), Quantitative PCR (qPCR) For Single Cells, Single-Cell Gene Expression Analysis Kits

3) By Single-Cell Proteomics: Mass Spectrometry-Based Proteomics, Antibody-Based Protein Analysis, Single-Cell Protein Analysis Kits

4) By Single-Cell Metabolomics: Mass Spectrometry For Metabolites, Nuclear Magnetic Resonance (NMR) Metabolomics, Single-Cell Metabolite Profiling Kits

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12379&type=smp

Which leading companies are shaping the growth of the single-cell omics market?

Major companies operating in the single-cell omics market include Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE HealthCare Technologies Inc., Thermo Fischer Scientific Inc., Agilent Technologies Inc., Sartorius AG, Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen N.V, DiaSorin S.p.A., Tecan Group Ltd., BGI Genomics Co. Ltd., Promega Corporation, 10x Genomics Inc., Takara Bio Inc., NanoString Technologies Inc., Vizgen, HiFiBiO Therapeutics, Deepcell, Immunai, Mission Bio Inc., Standard BioTools Inc., CYTENA GmbH, Celsius Therapeutics, Scailyte AG, Single Cell Discoveries, ImmunoScape Pte. Ltd., Nodexus Inc., 1CellBio Inc.

What key trends are currently impacting the single-cell omics market’s development?

In the single-cell omics market, product innovation is emerging as a predominant trend. To maintain a competitive edge, leading firms in the sector are focusing on creating novel products. In a noteworthy development, Deepcell, a US firm specialising in software for single-cell dimensional morphology analysis, unveiled its REM-I Platform in May 2023. This scalable single-cell imaging, high-dimensional analysis and cell sorting platform delivers unprecedented insights into cell biology. By integrating single-cell imaging, sorting and high-dimensional analysis, the REM-I Platform promises to unlock new avenues for discovery across various fields such as cancer biology, developmental biology, stem cell biology, gene therapy, and functional screening.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12379

Which geographic areas are influencing the growth of the single-cell omics market?

North America was the largest region in the single-cell omics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single-cell omics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Cell and Gene Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-and-genes-therapy-global-market-report

3D Cell Culture Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Culture Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: